- Home
- PCVX vs RHI Comparison
PCVX vs RHI Comparison
Compare PCVX & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- RHI
- Stock Information
- Founded
- PCVX 2013
- RHI 1948
- Country
- PCVX United States
- RHI United States
- Employees
- PCVX N/A
- RHI N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- RHI Professional Services
- Sector
- PCVX Health Care
- RHI Consumer Discretionary
- Exchange
- PCVX Nasdaq
- RHI Nasdaq
- Market Cap
- PCVX 4.0B
- RHI 3.5B
- IPO Year
- PCVX 2020
- RHI N/A
- Fundamental
- Price
- PCVX $42.66
- RHI $34.44
- Analyst Decision
- PCVX Strong Buy
- RHI Hold
- Analyst Count
- PCVX 8
- RHI 5
- Target Price
- PCVX $114.17
- RHI $49.80
- AVG Volume (30 Days)
- PCVX 2.0M
- RHI 1.7M
- Earning Date
- PCVX 11-04-2025
- RHI 10-21-2025
- Dividend Yield
- PCVX N/A
- RHI 6.85%
- EPS Growth
- PCVX N/A
- RHI N/A
- EPS
- PCVX N/A
- RHI 1.75
- Revenue
- PCVX N/A
- RHI $5,569,026,000.00
- Revenue This Year
- PCVX N/A
- RHI N/A
- Revenue Next Year
- PCVX N/A
- RHI $3.32
- P/E Ratio
- PCVX N/A
- RHI $19.64
- Revenue Growth
- PCVX N/A
- RHI N/A
- 52 Week Low
- PCVX $27.66
- RHI $33.18
- 52 Week High
- PCVX $118.62
- RHI $78.41
- Technical
- Relative Strength Index (RSI)
- PCVX 79.03
- RHI 44.92
- Support Level
- PCVX $31.89
- RHI $33.20
- Resistance Level
- PCVX $33.93
- RHI $34.58
- Average True Range (ATR)
- PCVX 1.80
- RHI 1.06
- MACD
- PCVX 1.05
- RHI 0.05
- Stochastic Oscillator
- PCVX 96.26
- RHI 37.35
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.